Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RCAT✓SelectedUSD · RCATGSK vs RCAT performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs RCAT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.4%
RCAT return
+310.5%
Excess return
-246.1%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioRCATExcessAlpha
1D-0.1%-7.1%+7.0%-0.2%
7D-1.3%-21.6%+20.2%-1.7%
30D+2.7%-25.2%+27.9%+2.4%
3M+2.7%-68.3%+71.0%+1.1%
6M+3.3%-62.8%+66.1%+2.2%
YTD+6.5%-55.5%+61.9%+5.6%
1Y+10.7%-50.7%+61.4%+9.9%
3Y+64.4%+304.4%-240.0%+62.9%
All+64.4%+310.5%-246.1%+62.9%

Cumulative growth

Daily Returns

Daily percentage return beside RCAT.

Daily Out/Under-Performance

Portfolio return minus RCAT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling